IndraLab

Statements

UCHL5 bound to NFRKB inhibits Stomach Neoplasms. 1 / 1

| 1

reach

"In gastric cancer, DRAIC combined with UCHL5 to attenuate the binding of UCHL5 and NFRKB, thereby promoting the degradation of NFRKB via ubiquitination and inhibiting the proliferation and metastasis [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

36328194

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

UCHL5 bound to NFRKB inhibits Stomach Neoplasms. 1 / 1

INDRA sources:

Databases

Reading